{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:30:02Z","timestamp":1793694602126,"version":"4.5.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00120-026-02927-z","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:09:28Z","timestamp":1789830568000},"page":"1138-1149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hormontherapie bei Geschlechtsinkongruenz: \u201eState of the art\u201c","Gender-affirming hormone therapy: state of the art"],"prefix":"10.1007","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7700-2915","authenticated-orcid":false,"given":"Jenny","family":"Bischoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"issue":"11","key":"2927_CR1","first-page":"370","volume":"121","author":"CJ Bachmann","year":"2024","unstructured":"Bachmann\u00a0CJ, Golub\u00a0Y, Holstiege\u00a0J et\u00a0al (2024) Gender Identity Disorders Among Young People in Germany: Prevalence and Trends, 2013\u20132022. Dtsch Arztebl Int 121(11):370\u2013371","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"2927_CR2","first-page":"48","volume":"7","author":"K Poge","year":"2022","unstructured":"Poge\u00a0K, Rommel\u00a0A, Starker\u00a0A et\u00a0al (2022) Survey of sex\/gender diversity in the GEDA 2019\/2020-EHIS study - objectives, procedure and experiences. J\u00a0Health Monit 7(2):48\u201365","journal-title":"J Health Monit"},{"issue":"Suppl\u00a01","key":"2927_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","volume":"23","author":"E Coleman","year":"2022","unstructured":"Coleman\u00a0E, Radix\u00a0AE, Bouman\u00a0WP et\u00a0al (2022) Standards of Care for the Health of Transgender and Gender Diverse People, Version\u00a08. Int J Transgend Health 23(Suppl\u00a01):S1\u2013S259","journal-title":"Int J Transgend Health"},{"issue":"43","key":"2927_CR4","first-page":"725","volume":"117","author":"G Meyer","year":"2020","unstructured":"Meyer\u00a0G, Boczek\u00a0U, Bojunga\u00a0J (2020) Hormonal Gender Reassignment Treatment for Gender Dysphoria. Dtsch Arztebl Int 117(43):725\u2013732","journal-title":"Dtsch Arztebl Int"},{"issue":"12","key":"2927_CR5","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.4158\/1934-2403-23.12.1437","volume":"23","author":"WC Hembree","year":"2017","unstructured":"Hembree\u00a0WC, Cohen-Kettenis\u00a0PT, Gooren\u00a0L et\u00a0al (2017) Endocrine Treatment of Gender-Dysphoric\/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. Endocr Pract 23(12):1437","journal-title":"Endocr Pract"},{"issue":"3","key":"2927_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.eprac.2021.11.081","volume":"28","author":"E Doll","year":"2022","unstructured":"Doll\u00a0E, Gunsolus\u00a0I, Thorgerson\u00a0A et\u00a0al (2022) Pharmacokinetics of Sublingual Versus Oral Estradiol in Transgender Women. Endocr Pract 28(3):237\u2013242","journal-title":"Endocr Pract"},{"issue":"5","key":"2927_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.eprac.2023.02.006","volume":"29","author":"JS Herndon","year":"2023","unstructured":"Herndon\u00a0JS, Maheshwari\u00a0AK, Nippoldt\u00a0TB et\u00a0al (2023) Comparison of the Subcutaneous and Intramuscular Estradiol Regimens as Part of Gender-Affirming Hormone Therapy. Endocr Pract 29(5):356\u2013361","journal-title":"Endocr Pract"},{"issue":"11","key":"2927_CR8","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.eprac.2025.07.002","volume":"31","author":"AL Misakian","year":"2025","unstructured":"Misakian\u00a0AL, Ariel\u00a0D, Sullivan\u00a0EA et\u00a0al (2025) Injectable Estradiol Monotherapy Effectively Suppresses Testosterone in Gender-Affirming Hormone Therapy. Endocr Pract 31(11):1462\u20131469","journal-title":"Endocr Pract"},{"issue":"9","key":"2927_CR9","doi-asserted-by":"publisher","first-page":"e2898","DOI":"10.1210\/clinem\/dgaf015","volume":"110","author":"AL Misakian","year":"2025","unstructured":"Misakian\u00a0AL, Kelley\u00a0CE, Sullivan\u00a0EA et\u00a0al (2025) Injectable Estradiol Use in Transgender and Gender-Diverse Individuals throughout the United States. J\u00a0Clin Endocrinol Metab 110(9):e2898\u2013e2907","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2927_CR10","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.eprac.2024.05.008","volume":"30","author":"MS Rothman","year":"2024","unstructured":"Rothman\u00a0MS, Ariel\u00a0D, Kelley\u00a0C et\u00a0al (2024) The Use of Injectable Estradiol in Transgender and Gender Diverse Adults: A Scoping Review of Dose and Serum Estradiol Levels. Endocr Pract 30(9):870\u2013878","journal-title":"Endocr Pract"},{"issue":"11","key":"2927_CR11","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1210\/jc.2017-01658","volume":"102","author":"WC Hembree","year":"2017","unstructured":"Hembree\u00a0WC, Cohen-Kettenis\u00a0PT, Gooren\u00a0L et\u00a0al (2017) Endocrine Treatment of Gender-Dysphoric\/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J\u00a0Clin Endocrinol Metab 102(11):3869\u20133903","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2927_CR12","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1182\/hematology.2024000592","volume":"2024","author":"H King","year":"2024","unstructured":"King\u00a0H, Kelley\u00a0TP, Shatzel\u00a0JJ (2024) Gender-affirming hormone therapy in the transgender patient: influence on thrombotic risk. Hematology Am Soc Hematol Educ Program 2024(1):652\u2013663","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3\u00a0Suppl","key":"2927_CR13","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/1097-0142(19930201)71:3+<1046::AID-CNCR2820711424>3.0.CO;2-M","volume":"71","author":"DG McLeod","year":"1993","unstructured":"McLeod\u00a0DG (1993) Antiandrogenic drugs. Cancer 71(3\u00a0Suppl):1046\u20131049","journal-title":"Cancer"},{"issue":"11","key":"2927_CR14","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.jsxm.2016.09.012","volume":"13","author":"R Fung","year":"2016","unstructured":"Fung\u00a0R, Hellstern-Layefsky\u00a0M, Tastenhoye\u00a0C et\u00a0al (2016) Differential Effects of Cyproterone Acetate vs Spironolactone on Serum High-Density Lipoprotein and Prolactin Concentrations in the Hormonal Treatment of Transgender Women. J\u00a0Sex Med 13(11):1765\u20131772","journal-title":"J Sex Med"},{"issue":"2","key":"2927_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/jnnp-2021-326138","volume":"93","author":"AP Mikkelsen","year":"2022","unstructured":"Mikkelsen\u00a0AP, Greiber\u00a0IK, Scheller\u00a0NM et\u00a0al (2022) Cyproterone acetate and risk of meningioma: a\u00a0nationwide cohort study. J\u00a0Neurol Neurosurg Psychiatry 93(2):222\u2013223","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2927_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n37","volume":"372","author":"A Weill","year":"2021","unstructured":"Weill\u00a0A, Nguyen\u00a0P, Labidi\u00a0M et\u00a0al (2021) Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study. BMJ 372:n37","journal-title":"BMJ"},{"issue":"12","key":"2927_CR17","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.eprac.2022.08.012","volume":"28","author":"KT Patel","year":"2022","unstructured":"Patel\u00a0KT, Adeel\u00a0S, Rodrigues Miragaya\u00a0J et\u00a0al (2022) Progestogen Use in Gender-Affirming Hormone Therapy: A Systematic Review. Endocr Pract 28(12):1244\u20131252","journal-title":"Endocr Pract"},{"issue":"1","key":"2927_CR18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.japh.2023.08.001","volume":"64","author":"C Bahr","year":"2024","unstructured":"Bahr\u00a0C, Ewald\u00a0J, Dragovich\u00a0R et\u00a0al (2024) Effects of progesterone on gender affirmation outcomes as part of feminizing hormone therapy. J\u00a0Am Pharm Assoc (2003) 64(1):268\u2013272","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"4","key":"2927_CR19","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1210\/jc.2018-01777","volume":"104","author":"JC Prior","year":"2019","unstructured":"Prior\u00a0JC (2019) Progesterone Is Important for Transgender Women\u2019s Therapy-Applying Evidence for the Benefits of Progesterone in Ciswomen. J\u00a0Clin Endocrinol Metab 104(4):1181\u20131186","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2927_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/26895269.2020.1719951","volume":"21","author":"J Defreyne","year":"2020","unstructured":"Defreyne\u00a0J, Vanwonterghem\u00a0Y, Collet\u00a0S et\u00a0al (2020) Vaginal bleeding and spotting in transgender men after initiation of testosterone therapy: A prospective cohort study (ENIGI). Int J Transgend Health 21(2):163\u2013175","journal-title":"Int J Transgend Health"},{"issue":"10","key":"2927_CR21","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/ced\/llad203","volume":"48","author":"GT Tang","year":"2023","unstructured":"Tang\u00a0GT, Zwickl\u00a0S, Sinclair\u00a0R et\u00a0al (2023) Effect of gender-affirming hormone therapy on hair growth: a\u00a0systematic review of the literature. Clin Exp Dermatol 48(10):1117\u20131127","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"2927_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/humrep\/deaf216","volume":"41","author":"Y Wilk Goldsher","year":"2026","unstructured":"Wilk Goldsher\u00a0Y, Al-Hadi\u00a0H, Mullen\u00a0B et\u00a0al (2026) Impact of gender-affirming hormone therapy on spermatogenesis: analysis of testicular histological specimens. Hum Reprod 41(1):78\u201385","journal-title":"Hum Reprod"},{"issue":"5","key":"2927_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jsxm.2018.03.083","volume":"15","author":"MK Auer","year":"2018","unstructured":"Auer\u00a0MK, Fuss\u00a0J, Nieder\u00a0TO et\u00a0al (2018) Desire to Have Children Among Transgender People in Germany: A Cross-Sectional Multi-Center Study. J\u00a0Sex Med 15(5):757\u2013767","journal-title":"J Sex Med"},{"key":"2927_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2023.102312","volume":"87","author":"THR Stolk","year":"2023","unstructured":"Stolk\u00a0THR, Asseler\u00a0JD, Huirne\u00a0JAF et\u00a0al (2023) Desire for children and fertility preservation in transgender and gender-diverse people: A systematic review. Best Pract Res Clin Obstet Gynaecol 87:102312","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2927_CR25","doi-asserted-by":"crossref","unstructured":"Cocchetti C, Ristori J, Romani A, et\u00a0al. Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals. J\u00a0Clin Med. 2020;9(6).","DOI":"10.3390\/jcm9061609"},{"issue":"2","key":"2927_CR26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1089\/trgh.2022.0202","volume":"10","author":"SD Thomas","year":"2025","unstructured":"Thomas\u00a0SD, Dempsey\u00a0M, King\u00a0RJ et\u00a0al (2025) Health Care Avoidance and Delay in the Transgender Population: A Systematic Review Exploring Associations with Minority Stress. Transgend Health 10(2):126\u2013149","journal-title":"Transgend Health"},{"issue":"1","key":"2927_CR27","doi-asserted-by":"publisher","DOI":"10.1080\/13814788.2023.2296571","volume":"30","author":"D Holland","year":"2024","unstructured":"Holland\u00a0D, White\u00a0LCJ, Pantelic\u00a0M et\u00a0al (2024) The experiences of transgender and nonbinary adults in primary care: A systematic review. Eur J Gen Pract 30(1):2296571","journal-title":"Eur J Gen Pract"},{"issue":"3","key":"2927_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11154-018-9449-0","volume":"19","author":"LJ Gooren","year":"2018","unstructured":"Gooren\u00a0LJ, T\u2019Sjoen\u00a0G (2018) Endocrine treatment of aging transgender people. Rev Endocr Metab Disord 19(3):253\u2013262","journal-title":"Rev Endocr Metab Disord"}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-026-02927-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-026-02927-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-026-02927-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:02:09Z","timestamp":1793692929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-026-02927-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2927"],"URL":"https:\/\/doi.org\/10.1007\/s00120-026-02927-z","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"value":"2731-7064","type":"print"},{"value":"2731-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"assertion":[{"value":"2 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.\u00a0Bischoff gibt an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}